SAB Biotherapeutics, Inc.
SEC Filing List
SABS CIK: 0001833214
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| SCHEDULE 13G | 05/15/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Sab Biotherapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| 8-K | Current report filing | Sab Biotherapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| SCHEDULE 13G | Toppan Merrill/FA | 05/01/2026 | |||
| DEF 14A | Definitive proxy statements | Sab Biotherapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/30/2026 | |
| 8-K | Current report filing | Sab Biotherapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/22/2026 | |
| S-8 | Initial registration statement for secur... | Sab Biotherapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/31/2026 | |
| 4 | Statement of changes in beneficial owner... | Kropotova Alexandra | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/25/2026 | |
| No record found. | |||||
| Load More | |||||
